摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-((bis-(tert-butyl))phosphono-difluoromethyl)-2-naphthoic acid | 219316-47-9

中文名称
——
中文别名
——
英文名称
6-((bis-(tert-butyl))phosphono-difluoromethyl)-2-naphthoic acid
英文别名
6-[[Bis[(2-methylpropan-2-yl)oxy]-oxidophosphaniumyl]-difluoromethyl]naphthalene-2-carboxylic acid;6-[[bis[(2-methylpropan-2-yl)oxy]-oxidophosphaniumyl]-difluoromethyl]naphthalene-2-carboxylic acid
6-((bis-(tert-butyl))phosphono-difluoromethyl)-2-naphthoic acid化学式
CAS
219316-47-9
化学式
C20H25F2O5P
mdl
——
分子量
414.386
InChiKey
ZJWBGVVSJSAXAV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    28
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    78.8
  • 氢给体数:
    1
  • 氢受体数:
    7

反应信息

  • 作为反应物:
    描述:
    6-((bis-(tert-butyl))phosphono-difluoromethyl)-2-naphthoic acid4-二甲氨基吡啶盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺三氟乙酸 作用下, 生成 [(6-Benzenesulfonylaminocarbonyl-naphthalen-2-yl)-difluoro-methyl]-phosphonic acid
    参考文献:
    名称:
    Acylsulfonamide-containing PTP1B inhibitors designed to mimic an enzyme-bound water of hydration
    摘要:
    Previously, it had been reported that 6-(phosphonodifluoromethyl)-2-naphthoic acid binds to the protein-tyrosine phosphatase PTP1B with its 2-carboxyl group interacting only indirectly through a bridging water molecule. Reported herein is a family of new analogues that utilize acylsulfonamido functionality both to mimic this water of hydration and to provide an additional new site for elaboration not found in the parent carboxyl-containing analogue. Target acylsulfonamides were prepared in two steps from commercially available primary sulfonamides, which were selected based on in silico screening for their potential ability to interact with one of three binding surfaces proximal to the PTP1B catalytic site. In general, modest potency enhancements were observed. Arylacylsulfonamides represent a structure-based extension of inhibitor design that may have broader utility in the development of PTP1B inhibitors. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(03)00635-8
  • 作为产物:
    描述:
    6-[(Di-tert-butoxy-phosphoryl)-difluoro-methyl]-naphthalene-2-carboxylic acid benzyl ester 在 lithium hydroxide 作用下, 以 四氢呋喃 为溶剂, 反应 3.5h, 以74%的产率得到6-((bis-(tert-butyl))phosphono-difluoromethyl)-2-naphthoic acid
    参考文献:
    名称:
    Structure-based design and synthesis of small molecule protein–tyrosine phosphatase 1B inhibitors
    摘要:
    Protein-tyrosine phosphatase (PTP) inhibitors are attractive as potential signal transduction-directed therapeutics which may be useful in the treatment of a variety of diseases. We have previously reported the X-ray structure of 1,1-difluoro-1-(2-naphthalenyl)methyl] phosphonic acid (4) complexed with the human the protein-tyrosine phosphatase 1B (PTP1B) and its use in the design of an analogue which binds with higher affinity within the catalytic site (Burke, T. R., Jr. et al. Biochemistry 1996, 35, 15989). In the current study, new naphthyldifluoromethyl phosphonic acids were designed bearing acidic functionality intended to interact with the PTP1B Arg47, which is situated just outside the catalytic pocket. This residue has been shown previously to provide key interactions with acidic residues of phosphotyrosyl-containing peptide substrates. Consistent with trends predicted by molecular dynamics calculations, the new analogues bound with 7- to 14-fold higher affinity than the parent 4, in principal validating the design rationale. (C) 1998 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(98)00140-0
点击查看最新优质反应信息

文献信息

  • Structure-based design and synthesis of small molecule protein–tyrosine phosphatase 1B inhibitors
    作者:Zhu-Jun Yao、Bin Ye、Xiong-Wu Wu、Shaomeng Wang、Li Wu、Zhong-Yin Zhang、Terrence R. Burke
    DOI:10.1016/s0968-0896(98)00140-0
    日期:1998.10
    Protein-tyrosine phosphatase (PTP) inhibitors are attractive as potential signal transduction-directed therapeutics which may be useful in the treatment of a variety of diseases. We have previously reported the X-ray structure of 1,1-difluoro-1-(2-naphthalenyl)methyl] phosphonic acid (4) complexed with the human the protein-tyrosine phosphatase 1B (PTP1B) and its use in the design of an analogue which binds with higher affinity within the catalytic site (Burke, T. R., Jr. et al. Biochemistry 1996, 35, 15989). In the current study, new naphthyldifluoromethyl phosphonic acids were designed bearing acidic functionality intended to interact with the PTP1B Arg47, which is situated just outside the catalytic pocket. This residue has been shown previously to provide key interactions with acidic residues of phosphotyrosyl-containing peptide substrates. Consistent with trends predicted by molecular dynamics calculations, the new analogues bound with 7- to 14-fold higher affinity than the parent 4, in principal validating the design rationale. (C) 1998 Elsevier Science Ltd. All rights reserved.
  • Acylsulfonamide-containing PTP1B inhibitors designed to mimic an enzyme-bound water of hydration
    作者:Ding-Guo Liu、Yang Gao、Johannes H. Voigt、Kyeong Lee、Marc C. Nicklaus、Li Wu、Zhong-Yin Zhang、Terrence R. Burke
    DOI:10.1016/s0960-894x(03)00635-8
    日期:2003.9
    Previously, it had been reported that 6-(phosphonodifluoromethyl)-2-naphthoic acid binds to the protein-tyrosine phosphatase PTP1B with its 2-carboxyl group interacting only indirectly through a bridging water molecule. Reported herein is a family of new analogues that utilize acylsulfonamido functionality both to mimic this water of hydration and to provide an additional new site for elaboration not found in the parent carboxyl-containing analogue. Target acylsulfonamides were prepared in two steps from commercially available primary sulfonamides, which were selected based on in silico screening for their potential ability to interact with one of three binding surfaces proximal to the PTP1B catalytic site. In general, modest potency enhancements were observed. Arylacylsulfonamides represent a structure-based extension of inhibitor design that may have broader utility in the development of PTP1B inhibitors. (C) 2003 Elsevier Ltd. All rights reserved.
查看更多